Articles

7 Questions to Evolve Your Privacy Strategy

Imagine if every time you wanted to drive your car, you had to inspect and reinstall the seatbelts, airbags...

3 Core Steps to Developing a Robust Privacy Strategy

Patient, device, or other protected data has emerged as an invaluable resource for many organizations in their quest to develop novel and innovative products and offerings.

How Context Affects Anonymization in AI Model Development

Building an AI model can require large amounts of data about people, and this data needs to be appropriately handled and managed.

Data Privacy, AI, De-identification, and Anonymization: Putting It All Together

In 2024, we shared several short articles about de-identified or anonymized data. Here, we take a look at how they intersect.

Why Context Matters When Anonymizing Data

If you’ve been involved in anonymization projects (such as Expert Determinations under HIPAA), you may have been asked to describe the data context in detail: ...

How to Work Safely with Unstructured Text Data

Unstructured data sources—including text, images, audio, and video—are rich sources of information.

Data Privacy Considerations for DICOM Anonymization

Across industries, demand for medical images is on the rise. This is due to increased use cases, such as AI, which can support applications for diagnostics

Motivated Intruder Testing – What, How, and Why?

Many organizations are familiar with statistical assessments of identifiability, like Expert Determinations under HIPAA or anonymization assessments under other regulations like the GPDR.

Anonymization at Scale: From Dataset to Pipeline

In the evolving landscape of data enablement, the need to leverage data for driving efficiency, spurring innovation, and fostering collaboration has never been greater.

How anonymization can enrich every stage of the drug development lifecycle

I wrote in our September newsletter about how trial sponsors are well advised to view transparency as much more than just a box that has to be checked off.

Putting Our Passion into Action Against COVID-19

Privacy Analytics is wholly committed to the global effort to respond to COVID-19.

Can You Comply Your Way to Greatness?

Compliance is important, and the first step for many transparency programs needing to satisfy EMA Policy 0070 and new Health Canada guidance.

When to Integrate Anonymization of Documents and Data

Should sponsors integrate risk-based anonymization across both documents and structured individual patient data (S-IPD)?

Learning at Scale: Anonymizing Unstructured Data using AI/ML

Unstructured data, such as medical notes, pose unique challenges with regards to anonymization.

Early Impact of Health Canada’s New Guidelines

Health Canada has introduced new regulatory guidance for anonymizing clinical study reports.

“Zero Risk Does Not Exist”

Privacy Rights in the Digital Era was the headline theme for this event.

Making healthcare big data & AI work for everyone, every day: Business Brunch in Zurich

“Making healthcare big data & AI work for everyone, every day” was held on November 21 2018 at Au Premier in Zürich, Switzerland.

How to become a data de-identification expert

A not-for-profit organization founded in 2007, with corporate offices in Frisco, Texas, the HITRUST Alliance champions programs that safeguard sensitive information...

Data Privacy as Business Driver: CDAO Frankfurt 2018

Presented by Corinium Global Intelligence, and sponsored in part by Privacy Analytics, among a distinguished list of global organizations...

Data Privacy Benchmarking: HITRUST 2018

HITRUST 2018 is the only event dedicated to exploring all aspects of risk management, information security, privacy and utilization...

Privacy Analytics partners with Vivli to enhance access to clinical trials data

Privacy Analytics is pleased to partner with Vivli: a new, groundbreaking digital platform where researchers can request and analyze clinical trial data...

Filter by Data Type

Categories